We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xceleron and Sanofi-Aventis Sign Deal to Address Challenges in Exploratory Clinical Development

News   Jun 12, 2007

 
Xceleron and Sanofi-Aventis Sign Deal to Address Challenges in Exploratory Clinical Development
 
 
 

RELATED ARTICLES

Unacceptable Levels of Harmful Chemical Found in Dried and Frozen Spices and Herbs

News

High levels of 1,2-unsaturated PA, known to be harmful to health, were detected in borage, as well as in some samples of commercially purchased deep-frozen and dried lovage, oregano and marjoram.

READ MORE

Casting a Spotlight on Cancer Metabolism With Bioluminescence

News

Scientists have invented a new way to quantify - in real-time - glucose metabolism of cancerous tumors by making them bioluminesce.

READ MORE

Good Compliance in Minimizing Veterinary Drug Residues in Food

News

Monitoring data on the presence of residues of veterinary medicines and contaminants in animals and animal-derived food show high rates of compliance with recommended safety levels.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE